P. Perini

Early Virological Failure after Tenofovir + Didanosine + Efavirenz Combination in HIV-Positive Patients upon Starting Antiretroviral Therapy

A. Antinori, C. Torti, G. Carosi, 2005, Antiviral therapy.

Characterisation of AIDS presenters and their response to antiretroviral therapy at legnano general hospital (Italy) during the period 2000-2008.

M. De Paschale, T. Cerulli, D. Cagnin, 2010, The new microbiologica.

Comparison of three therapeutic regimens for genotype‐3 hepatitis C virus infection in a large real‐life multicentre cohort

A. d’Arminio Monforte, S. Lazzaroni, M. Valsecchi, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non‐A, non‐B hepatitis

C. Ring, L. Barbara, M. Miglioli, 1992, Journal of medical virology.

High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV‐infected patients treated in a real‐life setting

R. Bruno, M. Colaneri, P. Lampertico, 2020, Journal of viral hepatitis.

Epidemiology of HIV-1 subtypes in an urban area of northern Italy.

A. Gatti, M. De Paschale, T. Cerulli, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Long-term persistence of IgM antibodies to HCV in chronic hepatitis C.

L. Barbara, M. Miglioli, P. Perini, 1993, Journal of Hepatology.